Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Myeloid 1Genitourinary 1Endocrine 1Breast 1

Conditions

Breast Neoplasms 25Neoplasms 12Prostatic Neoplasms 9Multiple Myeloma 9Neoplasm Metastasis 7Giant Cell Tumor of Bone 7Osteoporosis 4Fractures, Bone 4Recurrence 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Bone Diseases, Metabolic 3Bone Diseases 3Spinal Cord Compression 2Smoldering Multiple Myeloma 2Parathyroid Neoplasms 2Melanoma 2Lymphoma 2Lung Neoplasms 2Bone Neoplasms 2Bone Metastases 2Bone Cysts, Aneurysmal 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer Metastatic 1Paraproteinemias 1Pancreatic Neoplasms 1

Interventions

Zoledronic Acid 16Risedronic Acid 9Vitamin D 8Calcium 8Letrozole 6Cholecalciferol 5Calcium Carbonate 5Alendronate 5Denosumab 4Absorptiometry, Photon 4Calcium Gluconate 3parathyroid hormone-related peptide (1-36) 2bicalutamide 2Resistance Training 2Progesterone 2Nutrition Assessment 2Kyphoplasty 2Hormone Replacement Therapy 2Goserelin 2Estradiol 2Calcium Citrate 2xian ling gu bao 1romosozumab 1X-Rays 1Toremifene 1Testosterone 1Technetium 1Spectrum Analysis 1Raloxifene Hydrochloride 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Osteoporosis × Denosumab × Clear all
NCT03401060 2026-03-31

DenosuMast

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
24 enrolled
Myeloid

Osteoporosis, Mastocytosis, Systemic

NCT03811509 2019-01-28

B-ABLE

Parc de Salut Mar

Phase 4 Unknown
1,000 enrolled
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Osteoporotic Fractures, Musculoskeletal Pain

NCT00980174 2018-10-17

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Amgen

Phase 3 Completed
242 enrolled 19 charts
Endocrine

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

NCT00925600 2017-05-30

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

Amgen

Phase 3 Completed
769 enrolled 21 charts
Genitourinary

Bone Diseases, Metabolic, Cataract, Neoplasms, Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡